A Home-Grown Company Helping Save Lives Every Day
A Home-Grown Company Helping Save Lives Every Day
Latde Diagnostics Wins Lever’s Western Massachusetts Health Technology Challenge
Latde Diagnostics won $50,000 and Quaesar Therapeutics won $25,000 in Lever Innovation Grant funding after competing in Lever’s Western Mass Health Tech Challenge on Friday, March 3rd at the Institute...
Read MoreA Conversation With Henrietta Binortsor and Alexis Jackson
The Massachusetts Life Sciences Center (MLSC) team knows the strongest life sciences sector is a diverse one. Diversity, Equity, and Inclusion (DE&I) is a foundational piece of the MLSC’s Strategic...
Read MoreCERES Lab Offers Industry Researchers Opportunity to Accelerate Development of Innovative Health Treatments
Kenneth Dwyer, a sales and marketing professional with extensive experience in the life sciences industry, has joined WPI as laboratory manager of the university’s Cell Engineering Research Equipment Suite (CERES)...
Read MoreMassachusetts Life Sciences Center Announces Awardees for Public-Private Initiative to Support Women Entrepreneurs
2022 MassNexGen Awardees culminate five-year initiative to catalyze gender parity in life science entrepreneurship within the Commonwealth Today, the Massachusetts Life Sciences Center (MLSC) announced the 2022 winners for the...
Read MoreConcerto Biosciences Raises $23 Million in Series A to Advance Product Development, Expand Pipeline
Concerto Biosciences, a biotechnology company designing microbial communities that restore deficient microbiomes to treat disease, announced today that it raised $23 million in a Series A funding round led by...
Read MoreNucleate Boston partners with the Massachusetts Life Science Center to support the formation of early-stage biotech ventures
Today, the Nucleate Boston chapter is proud to announce its partnership with the Massachusetts Life Sciences Center (MLSC). As a Platinum level regional partner, the MLSC will provide funding totaling...
Read MoreAlloy Therapeutics Raises $42 Million Series D Financing to Accelerate Discovery Technology Development Across Biologic Modalities
Alloy Therapeutics, a biotechnology ecosystem company, has closed $42 million in Series D financing led by its existing investors 8VC and Mubadala Capital and joined by return investors Thiel Capital,...
Read MoreMLSC Launches 2022-2023 Women’s Health Programming Round
The MLSC is excited to launch the next round of programming for its Women’s Health Initiative: First Look Awards, Innovation Grants, and Collaboration program. The deadline to apply for the 2022-2023 program...
Read More